A new era is unfolding in India’s pharmaceutical landscape in 2025, where innovation, collaboration, and regulatory rigor are driving transformative growth. From cutting-edge drug launches and strategic partnerships to the adoption of AI, digital health, and high-quality lab solutions, the sector is redefining patient care and global competitiveness.
With government initiatives, advanced manufacturing, and talent-driven Global Capability Centres fueling progress, India is emerging as a hub where scientific excellence, affordability, and strategic foresight converge... >>More
Rashmi Pimpale, CEO, Research and Innovation Circle of Hyderabad (RICH)
Nagalakshmi Shetty, Head India & Vice President, Clinical Data Science, ICON plc
Rajiv Gupta, Country Business Leader (Healthcare Business), 3M India
Amit Sehgal, VP & GM - Lab Solutions Segment, AMEA, Avantor
Ashutosh K Sinha, Chief Quality Officer, Neuland Laboratories Limited